ORBIMED ADVISORS LLC 13D/13G Filings for Traws Pharma, Inc. (TRAW)

ORBIMED ADVISORS LLC 13D and 13G filings for Traws Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-01-29
6:42 pm
Purchase		 2024-12-31 13D Traws Pharma, Inc.
TRAW		 ORBIMED ADVISORS LLC 760,824
19.900%		 155,293increase
(+25.65%)		 Filing
2024-11-06
4:12 pm
Purchase		 2024-09-16 13D Traws Pharma, Inc.
TRAW		 ORBIMED ADVISORS LLC 605,531
19.900%		 3,531increase
(+0.59%)		 Filing
2024-09-23
6:44 pm
Purchase		 2024-09-16 13D Traws Pharma, Inc.
TRAW		 ORBIMED ADVISORS LLC 602,000
19.900%		 602,000increase
(New Position)		 Filing